These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Portal hemodynamics in dogs during mechanical ventilation with positive end-expiratory pressure. Bredenberg CE; Paskanik A; Fromm D Surgery; 1981 Nov; 90(5):817-22. PubMed ID: 7029764 [TBL] [Abstract][Full Text] [Related]
23. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension. Oberti F; Sogni P; Cailmail S; Moreau R; Pipy B; Lebrec D Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803 [TBL] [Abstract][Full Text] [Related]
24. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats]. Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats. Huang YT; Tsai JF; Lin HC; Chen CF; Hong CY Can J Physiol Pharmacol; 1997; 75(10-11):1220-5. PubMed ID: 9431446 [TBL] [Abstract][Full Text] [Related]
26. Effects of pentobarbital sodium anesthesia on splanchnic hemodynamics of normal and portal-hypertensive rats. Lee SS; Girod C; Valla D; Geoffroy P; Lebrec D Am J Physiol; 1985 Oct; 249(4 Pt 1):G528-32. PubMed ID: 4051000 [TBL] [Abstract][Full Text] [Related]
27. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension. Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152 [TBL] [Abstract][Full Text] [Related]
28. An animal study of portal hypertension. Lay CS; Yang CM; Tsai YT; Chen HI; Simchon S; Chien S Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jul; 44(1):19-24. PubMed ID: 2819564 [TBL] [Abstract][Full Text] [Related]
29. Hemodynamic effects of hypothyroidism induced by methimazole in normal and portal hypertensive rats. Oren R; Hilzenrat N; Maaravi Y; Yaari A; Sikuler E Dig Dis Sci; 1995 Sep; 40(9):1941-5. PubMed ID: 7555447 [TBL] [Abstract][Full Text] [Related]
30. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics. Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003 [TBL] [Abstract][Full Text] [Related]
31. Lack of a correlation between portal vein flow and pressure: toward a shared interpretation of hemodynamic stress governing inflow modulation in liver transplantation. Sainz-Barriga M; Scudeller L; Costa MG; de Hemptinne B; Troisi RI Liver Transpl; 2011 Jul; 17(7):836-48. PubMed ID: 21384528 [TBL] [Abstract][Full Text] [Related]
32. Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha. Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Wu SL; Tai CC; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):145-50. PubMed ID: 9198288 [TBL] [Abstract][Full Text] [Related]
33. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203 [TBL] [Abstract][Full Text] [Related]
34. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Colle I; De Vriese AS; Van Vlierberghe H; Lameire NH; DeVos M Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002 [TBL] [Abstract][Full Text] [Related]
35. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Sikuler E; Kravetz D; Groszmann RJ Am J Physiol; 1985 Jun; 248(6 Pt 1):G618-25. PubMed ID: 4003545 [TBL] [Abstract][Full Text] [Related]
36. Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis. Steib CJ; Hartmann AC; v Hesler C; Benesic A; Hennenberg M; Bilzer M; Gerbes AL Lab Invest; 2010 Jul; 90(7):1024-32. PubMed ID: 20212458 [TBL] [Abstract][Full Text] [Related]
37. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats. Cao H; Wu Z; Zhou J; Chen Z; Kuang Y Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330 [TBL] [Abstract][Full Text] [Related]
38. Aliskiren reduces portal pressure in portal hypertensive rats. Chang CC; Lee WS; Huang HC; Lee FY; Wang SS; Lin HC; Nong JY; Lee SD Eur J Clin Invest; 2012 May; 42(5):526-33. PubMed ID: 22023532 [TBL] [Abstract][Full Text] [Related]
39. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats. Nevens F; Pizcueta MP; Fernández M; Bosch J; Rodés J Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867 [TBL] [Abstract][Full Text] [Related]
40. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Casadevall M; Panés J; Piqué JM; Marroni N; Bosch J; Whittle BJ Hepatology; 1993 Sep; 18(3):628-34. PubMed ID: 8359804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]